| Year |
Citation |
Score |
| 2017 |
Lu S, Dong Z. Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells. International Journal of Oncology. PMID 28440478 DOI: 10.3892/Ijo.2017.3964 |
0.374 |
|
| 2015 |
Dillehay KL, Seibel WL, Zhao D, Lu S, Dong Z. Target validation and structure-activity analysis of a series of novel PCNA inhibitors. Pharmacology Research & Perspectives. 3: e00115. PMID 25729582 DOI: 10.1002/Prp2.115 |
0.323 |
|
| 2015 |
Smith SJ, Gu L, Phipps EA, Dobrolecki LE, Mabrey KS, Gulley P, Dillehay KL, Dong Z, Fields GB, Chen YR, Ann D, Hickey RJ, Malkas LH. A Peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interactions is cytotoxic to breast cancer. Molecular Pharmacology. 87: 263-76. PMID 25480843 DOI: 10.1124/Mol.114.093211 |
0.301 |
|
| 2014 |
Dillehay KL, Lu S, Dong Z. Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer. Molecular Cancer Therapeutics. 13: 2817-26. PMID 25253786 DOI: 10.1158/1535-7163.Mct-14-0522 |
0.389 |
|
| 2014 |
Dong Z, Meller J, Succop P, Wang J, Wikenheiser-Brokamp K, Starnes S, Lu S. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells. International Journal of Oncology. 45: 978-84. PMID 24913497 DOI: 10.3892/Ijo.2014.2486 |
0.313 |
|
| 2013 |
Hong D, Saha P, Chou DT, Lee B, Collins BE, Tan Z, Dong Z, Kumta PN. In vitro degradation and cytotoxicity response of Mg-4% Zn-0.5% Zr (ZK40) alloy as a potential biodegradable material. Acta Biomaterialia. 9: 8534-47. PMID 23851175 DOI: 10.1016/J.Actbio.2013.07.001 |
0.303 |
|
| 2012 |
Cui L, Chen P, Tan Z, Li W, Dong Z. Hemostatic gelatin sponge is a superior matrix to matrigel for establishment of LNCaP human prostate cancer in nude mice. The Prostate. 72: 1669-77. PMID 22473906 DOI: 10.1002/Pros.22520 |
0.391 |
|
| 2012 |
Tan Z, Wortman M, Dillehay KL, Seibel WL, Evelyn CR, Smith SJ, Malkas LH, Zheng Y, Lu S, Dong Z. Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth. Molecular Pharmacology. 81: 811-9. PMID 22399488 DOI: 10.1124/Mol.112.077735 |
0.354 |
|
| 2012 |
Tan Z, Chen P, Schneider N, Glover S, Cui L, Torgue J, Rixe O, Spitz HB, Dong Z. Significant systemic therapeutic effects of high-LET immunoradiation by 212Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice. International Journal of Oncology. 40: 1881-8. PMID 22322558 DOI: 10.3892/Ijo.2012.1357 |
0.368 |
|
| 2012 |
Oleksowicz L, Liu Y, Bracken RB, Gaitonde K, Burke B, Succop P, Levin L, Dong Z, Lu S. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer. The Prostate. 72: 1140-9. PMID 22127954 DOI: 10.1002/Pros.22463 |
0.332 |
|
| 2012 |
Tan Z, Chen P, Schneider N, Glover S, Cui L, Torgue J, Rixe O, Spitz HB, Dong Z. Abstract 5713: Significant systemic therapeutic effects of high-LET immunoradiation by212Pb-Trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice Cancer Research. 72: 5713-5713. DOI: 10.1158/1538-7445.Am2012-5713 |
0.38 |
|
| 2012 |
Lu S, Oleksowicz L, Liu Y, Bracken RB, Gaitonde K, Burke B, Succop P, Levin L, Dong Z. Abstract 3631: Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer Cancer Research. 72: 3631-3631. DOI: 10.1158/1538-7445.Am2012-3631 |
0.367 |
|
| 2011 |
Dong Z, Liu Y, Levin L, Oleksowicz L, Wang J, Lu S. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer. Oncology Reports. 25: 1511-6. PMID 21455584 DOI: 10.3892/Or.2011.1237 |
0.353 |
|
| 2010 |
Dong Z, Liu Y, Scott KF, Levin L, Gaitonde K, Bracken RB, Burke B, Zhai QJ, Wang J, Oleksowicz L, Lu S. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis. 31: 1948-55. PMID 20837598 DOI: 10.1093/Carcin/Bgq188 |
0.363 |
|
| 2010 |
Meng Q, Peng Z, Chen L, Si J, Dong Z, Xia Y. Nuclear Factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells. Cancer Letters. 299: 45-53. PMID 20810208 DOI: 10.1016/J.Canlet.2010.08.002 |
0.319 |
|
| 2010 |
Cho HS, Dong Z, Pauletti GM, Zhang J, Xu H, Gu H, Wang L, Ewing RC, Huth C, Wang F, Shi D. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. Acs Nano. 4: 5398-404. PMID 20707381 DOI: 10.1021/Nn101000E |
0.364 |
|
| 2010 |
Lu S, Tan Z, Wortman M, Lu S, Dong Z. Preferential induction of G1 arrest in androgen-responsive human prostate cancer cells by androgen receptor signaling antagonists DL3 and antiandrogen bicalutamide. Cancer Letters. 298: 250-7. PMID 20675041 DOI: 10.1016/J.Canlet.2010.07.012 |
0.354 |
|
| 2010 |
Yun Y, Dong Z, Tan Z, Schulz MJ. Development of an electrode cell impedance method to measure osteoblast cell activity in magnesium-conditioned media. Analytical and Bioanalytical Chemistry. 396: 3009-15. PMID 20213174 DOI: 10.1007/S00216-010-3521-2 |
0.327 |
|
| 2010 |
Liu Y, Wu X, Dong Z, Lu S. The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells. International Journal of Oncology. 36: 623-33. PMID 20126983 DOI: 10.3892/Ijo_00000538 |
0.341 |
|
| 2010 |
Lu S, Tan Z, Wortman M, Lu S, Dong Z. Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells. International Journal of Oncology. 36: 459-67. PMID 20043082 DOI: 10.3892/Ijo_00000520 |
0.355 |
|
| 2008 |
Liu Y, Mo JQ, Hu Q, Boivin G, Levin L, Lu S, Yang D, Dong Z, Lu S. Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer. Cancer Research. 68: 6396-406. PMID 18676865 DOI: 10.1158/0008-5472.Can-08-0645 |
0.345 |
|
| 2008 |
Lee K, Liu Y, Mo JQ, Zhang J, Dong Z, Lu S. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. Bmc Cancer. 8: 158. PMID 18518979 DOI: 10.1186/1471-2407-8-158 |
0.327 |
|
| 2008 |
Guo Y, Shi D, Cho H, Dong Z, Kulkarni A, Pauletti GM, Wang W, Lian J, Liu W, Ren L, Zhang Q, Liu G, Huth C, Wang L, Ewing RC. In vivo imaging and drug storage by quantum-dot-conjugated carbon nanotubes Advanced Functional Materials. 18: 2489-2497. DOI: 10.1002/Adfm.200800406 |
0.307 |
|
| 2007 |
Yun Y, Dong Z, Shanov VN, Schulz MJ. Electrochemical impedance measurement of prostate cancer cells using carbon nanotube array electrodes in a microfluidic channel. Nanotechnology. 18: 465505. PMID 21730479 DOI: 10.1088/0957-4484/18/46/465505 |
0.318 |
|
| 2007 |
Wang D, Lu S, Dong Z. Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide. The Prostate. 67: 1825-33. PMID 17941092 DOI: 10.1002/Pros.20669 |
0.356 |
|
| 2007 |
Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5692-702. PMID 17908958 DOI: 10.1158/1078-0432.Ccr-07-1078 |
0.358 |
|
| 2007 |
Lu S, Wang A, Lu S, Dong Z. A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells. Molecular Cancer Therapeutics. 6: 2057-64. PMID 17620434 DOI: 10.1158/1535-7163.Mct-06-0735 |
0.383 |
|
| 2006 |
Lee J, Wang A, Hu Q, Lu S, Dong Z. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice. International Journal of Oncology. 29: 1405-12. PMID 17088978 DOI: 10.3892/Ijo.29.6.1405 |
0.385 |
|
| 2006 |
Dong Z, Liu Y, Lu S, Wang A, Lee K, Wang LH, Revelo M, Lu S. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Molecular Endocrinology (Baltimore, Md.). 20: 2315-25. PMID 16762975 DOI: 10.1210/Me.2006-0048 |
0.384 |
|
| 2006 |
Lu S, Dong Z. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells. The Prostate. 66: 996-1004. PMID 16541418 DOI: 10.1002/Pros.20424 |
0.339 |
|
| 2006 |
Zhang F, Lee J, Wang D, Dong Z. Differential growth of IFN-beta-engineered tumor cells in nude and IFN receptor-null mice. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 26: 108-18. PMID 16487031 DOI: 10.1089/Jir.2006.26.108 |
0.329 |
|
| 2005 |
Zhang F, Lee J, Lu S, Pettaway CA, Dong Z. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4512-20. PMID 15958637 DOI: 10.1158/1078-0432.Ccr-04-2571 |
0.394 |
|
| 2003 |
Ozawa S, Lu W, Bucana CD, Kanayama HO, Shinohara H, Fidler IJ, Dong Z. Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-beta. International Journal of Oncology. 22: 977-84. PMID 12684662 DOI: 10.3892/Ijo.22.5.977 |
0.358 |
|
| 2002 |
Harmey JH, Bucana CD, Lu W, Byrne AM, McDonnell S, Lynch C, Bouchier-Hayes D, Dong Z. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. International Journal of Cancer. 101: 415-22. PMID 12216068 DOI: 10.1002/Ijc.10632 |
0.317 |
|
| 2002 |
Lu W, Dong Z, Donawho C, Fidler IJ. Specific immunotherapy against occult cancer metastases. International Journal of Cancer. 100: 480-5. PMID 12115534 DOI: 10.1002/Ijc.10494 |
0.305 |
|
| 2001 |
Zhang F, Zhao G, Dong Z. Phosphatidylcholine-specific phospholipase C regulates activation of RAW264.7 macrophage-like cells by lipopeptide JBT3002 Journal of Leukocyte Biology. 69: 1060-1066. DOI: 10.1189/Jlb.69.6.1060 |
0.342 |
|
| 2000 |
Kumar R, Eue I, Dong Z, Killion JJ, Fidler IJ. Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptide JT3002. Cancer Biotherapy & Radiopharmaceuticals. 12: 333-40. PMID 10851483 DOI: 10.1089/Cbr.1997.12.333 |
0.308 |
|
| 1999 |
Kumar R, Yoneda J, Fidler IJ, Dong Z. GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune-compromised mice. Journal of Leukocyte Biology. 65: 102-8. PMID 9886252 DOI: 10.1002/Jlb.65.1.102 |
0.348 |
|
| 1998 |
Eue I, Kumar R, Dong Z, Killion JJ, Fidler IJ. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes. Journal of Immunotherapy (Hagerstown, Md. : 1997). 21: 340-51. PMID 9789196 DOI: 10.1097/00002371-199809000-00002 |
0.339 |
|
| 1998 |
Dong Z, Yoneda J, Kumar R, Fidler IJ. Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor. The Journal of Experimental Medicine. 188: 755-63. PMID 9705957 DOI: 10.1084/Jem.188.4.755 |
0.348 |
|
| 1998 |
Dong Z, Juang SH, Kumar R, Eue I, Xie K, Bielenberg D, Lu W, Bucana C, Yang X, Fidler IJ. Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene. Cancer Immunology, Immunotherapy : Cii. 46: 137-46. PMID 9625537 DOI: 10.1007/S002620050472 |
0.345 |
|
| 1998 |
Dong Z, Killion JJ, Kumar R, Eue I, Yang X, Lu W, Su B, Fidler IJ. Activation of cytokine production, tumoricidal properties, and tyrosine phosphorylation of MAPKs in human monocytes by a new synthetic lipopeptide, JBT3002. Journal of Leukocyte Biology. 63: 766-74. PMID 9620671 DOI: 10.1002/Jlb.63.6.766 |
0.321 |
|
| 1997 |
Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 88: 801-10. PMID 9118223 DOI: 10.1016/S0092-8674(00)81926-1 |
0.341 |
|
| 1997 |
Xie K, Huang S, Dong Z, Juang SH, Wang Y, Fidler IJ. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. Journal of the National Cancer Institute. 89: 421-7. PMID 9091643 DOI: 10.1093/Jnci/89.6.421 |
0.345 |
|
| 1996 |
Xie K, Huang S, Wang Y, Beltran PJ, Juang SH, Dong Z, Reed JC, McDonnell TJ, McConkey DJ, Fidler IJ. Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis Cancer Immunology, Immunotherapy. 43: 109-115. PMID 8954145 DOI: 10.1007/S002620050310 |
0.331 |
|
| 1996 |
Xie K, Dong Z, Fidler IJ. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. Journal of Leukocyte Biology. 59: 797-803. PMID 8691063 DOI: 10.1002/Jlb.59.6.797 |
0.373 |
|
| 1995 |
Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C, Fidler IJ. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. The Journal of Experimental Medicine. 181: 1333-43. PMID 7535333 DOI: 10.1084/Jem.181.4.1333 |
0.321 |
|
| 1994 |
Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Reviews. 13: 209-22. PMID 7923551 DOI: 10.1007/Bf00689637 |
0.351 |
|
| 1993 |
Killion JJ, Radinsky R, Dong Z, Fishbeck R, Whitworth P, Fidler IJ. The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype. Cancer Immunology, Immunotherapy : Cii. 36: 381-6. PMID 8098991 DOI: 10.1007/Bf01742254 |
0.332 |
|
| 1993 |
Bucana CD, Radinsky R, Dong Z, Sanchez R, Brigati DJ, Fidler IJ. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 41: 499-506. PMID 8095509 DOI: 10.1177/41.4.8095509 |
0.303 |
|
| 1991 |
O'Brian CA, Fan D, Ward NE, Dong Z, Iwamoto L, Gupta KP, Earnest LE, Fidler IJ. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro Biochemical Pharmacology. 41: 797-806. PMID 1998534 DOI: 10.1016/0006-2952(91)90083-H |
0.313 |
|
| Show low-probability matches. |